| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Forefront Tech Holdings Acquisition Corp
13G
FTHA · G3624C106
|
9.0% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 9.0% | ||||
| Robert Atchinson | 9.0% | ||||
| Phillip Gross | 9.0% | ||||
|
Equillium, Inc.
13G/A
Amendment 1
EQ · 29446K106
|
7.3% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 7.3% | ||||
| Robert Atchinson | 7.3% | ||||
| Phillip Gross | 7.3% | ||||
|
Energy Transition Special Opportunities
13G
ETSS · G23017109
|
9.0% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 9.0% | ||||
| Robert Atchinson | 9.0% | ||||
| Phillip Gross | 9.0% | ||||
|
Cybin Inc.
13G
HELP · 23256X407
|
5.3% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 5.3% | ||||
| Robert Atchinson | 5.3% | ||||
| Phillip Gross | 5.3% | ||||
|
Yorkville International Capital Corp.
13G
G98665104
|
7.8% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 7.8% | ||||
| Robert Atchinson | 7.8% | ||||
| Phillip Gross | 7.8% | ||||
|
SCYNEXIS, Inc.
13G
SCYX · 811292309
|
10.0% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 10.0% | ||||
| Robert Atchinson | 10.0% | ||||
| Phillip Gross | 10.0% | ||||
|
XPLR Infrastructure, LP
13G
XIFR · 65341B106
|
6.6% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 6.6% | ||||
| Robert Atchinson | 6.6% | ||||
| Phillip Gross | 6.6% | ||||
|
Churchill Capital Corp XII
13G
CXII · G2131M102
|
6.5% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 6.5% | ||||
| Robert Atchinson | 6.5% | ||||
| Phillip Gross | 6.5% | ||||
|
SAB Biotherapeutics, Inc.
13G
SABS · 78397T202
|
8.4% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 8.4% | ||||
| Robert Atchinson | 8.4% | ||||
| Phillip Gross | 8.4% | ||||
|
RRE Ventures Acquisition Corp.
13G
RREV · G770AL103
|
9.0% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 9.0% | ||||
| Robert Atchinson | 9.0% | ||||
| Phillip Gross | 9.0% | ||||
|
West Enclave Merger Corp.
13G
WENC · G9600E107
|
5.6% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 5.6% | ||||
| Robert Atchinson | 5.6% | ||||
| Phillip Gross | 5.6% | ||||
|
Churchill Capital Corp XI
13G/A
Amendment 1
CCXI · G2131A108
|
1.9% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 1.9% | ||||
| Robert Atchinson | 1.9% | ||||
| Phillip Gross | 1.9% | ||||
|
RMG ML Sports Holdings
13G
SHOT · G7610P104
|
8.2% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 8.2% | ||||
| Robert Atchinson | 8.2% | ||||
| Phillip Gross | 8.2% | ||||
|
Viking Acquisition Corp I
13G/A
Amendment 1
VACI · G9582G104
|
6.0% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 6.0% | ||||
| Robert Atchinson | 6.0% | ||||
| Phillip Gross | 6.0% | ||||
|
CH4 Natural Solutions Corp
13G
MTNE · G2104X101
|
8.1% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 8.1% | ||||
| Robert Atchinson | 8.1% | ||||
| Phillip Gross | 8.1% | ||||
|
NextCure, Inc.
13G
NXTC · 65343E207
|
7.7% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 7.7% | ||||
| Robert Atchinson | 7.7% | ||||
| Phillip Gross | 7.7% | ||||
|
Texas Ventures Acquisition IV Corp
13G
TVIV · G8773A108
|
7.8% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 7.8% | ||||
| Robert Atchinson | 7.8% | ||||
| Phillip Gross | 7.8% | ||||
|
Centessa Pharmaceuticals plc
13G/A
Amendment 4
CNTA · 152309100
|
0% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 0% | ||||
| Robert Atchinson | 0% | ||||
| Phillip Gross | 0% | ||||
|
NewHold Investment Corp IV
13G
NHIV · G6486G107
|
7.6% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 7.6% | ||||
| Robert Atchinson | 7.6% | ||||
| Phillip Gross | 7.6% | ||||
|
Tenax Therapeutics, Inc.
13G/A
Amendment 1
TENX · 88032L605
|
6.8% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 6.8% | ||||
| Robert Atchinson | 6.8% | ||||
| Phillip Gross | 6.8% | ||||
|
Cabaletta Bio, Inc.
13G/A
Amendment 7
CABA · 12674W109
|
8.4% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 8.4% | ||||
| Robert Atchinson | 8.4% | ||||
| Phillip Gross | 8.4% | ||||
|
Monro, Inc.
13G/A
Amendment 1
MNRO · 610236101
|
3.2% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 3.2% | ||||
| Robert Atchinson | 3.2% | ||||
| Phillip Gross | 3.2% | ||||
|
Patriot Acquisition Corp.
13G
PTAC · G6951A106
|
8.2% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 8.2% | ||||
| Robert Atchinson | 8.2% | ||||
| Phillip Gross | 8.2% | ||||
|
Monopar Therapeutics Inc.
13G/A
Amendment 2
MNPR · 61023L207
|
4.8% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 4.8% | ||||
| Robert Atchinson | 4.8% | ||||
| Phillip Gross | 4.8% | ||||
|
Bright Minds Biosciences Inc.
13G/A
Amendment 1
DRUG · 10919W405
|
3.4% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 3.4% | ||||
| Robert Atchinson | 3.4% | ||||
| Phillip Gross | 3.4% | ||||
|
Oceanhawk Acquisition Corp.
13G
OHAC · G6722R107
|
5.7% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 5.7% | ||||
| Robert Atchinson | 5.7% | ||||
| Phillip Gross | 5.7% | ||||
|
Long Table Growth Corp.
13G
LTGR · G5701H106
|
7.8% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 7.8% | ||||
| Robert Atchinson | 7.8% | ||||
| Phillip Gross | 7.8% | ||||
|
Bleichroeder Acquisition Corp. II
13G/A
Amendment 1
BBCQ · G1170E104
|
3.7% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 3.7% | ||||
| Robert Atchinson | 3.7% | ||||
| Phillip Gross | 3.7% | ||||
|
Karyopharm Therapeutics Inc.
13G/A
Amendment 1
KPTI · 48576U205
|
6.8% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 6.8% | ||||
| Robert Atchinson | 6.8% | ||||
| Phillip Gross | 6.8% | ||||
|
KPET Ultra Paceline Corporation
13G
KPET · G53157106
|
7.8% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 7.8% | ||||
| Robert Atchinson | 7.8% | ||||
| Phillip Gross | 7.8% | ||||
|
Irenic Acquisition Corp.
13G
IACQ · G4939F107
|
7.6% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 7.6% | ||||
| Robert Atchinson | 7.6% | ||||
| Phillip Gross | 7.6% | ||||
|
Iron Dome Acquisition I Corp.
13G
IDAC · G4949K104
|
8.5% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 8.5% | ||||
| Robert Atchinson | 8.5% | ||||
| Phillip Gross | 8.5% | ||||
|
Aura Biosciences, Inc.
13G/A
Amendment 4
AURA · 05153U107
|
8.4% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 8.4% | ||||
| Robert Atchinson | 8.4% | ||||
| Phillip Gross | 8.4% | ||||
|
Inovio Pharmaceuticals, Inc.
13G/A
Amendment 2
INO · 45773H409
|
4.0% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 4.0% | ||||
| Robert Atchinson | 4.0% | ||||
| Phillip Gross | 4.0% | ||||
|
Inflection Point Acquisition Corp. VI
13G/A
Amendment 1
IPFX · G4790S107
|
4.2% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 4.2% | ||||
| Robert Atchinson | 4.2% | ||||
| Phillip Gross | 4.2% | ||||
|
AmperCap Acquisition Company
13G
APMC · G0344N107
|
5.6% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 5.6% | ||||
| Robert Atchinson | 5.6% | ||||
| Phillip Gross | 5.6% | ||||
|
Gores Holdings XI, Inc.
13G
GHXIU · G40008123
|
7.8% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 7.8% | ||||
| Robert Atchinson | 7.8% | ||||
| Phillip Gross | 7.8% | ||||
|
EyePoint, Inc.
13G
EYPT · 30233G209
|
5.7% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 5.7% | ||||
| Robert Atchinson | 5.7% | ||||
| Phillip Gross | 5.7% | ||||
|
Tango Therapeutics, Inc.
13G/A
Amendment 2
TNGX · 87583X109
|
3.4% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 3.4% | ||||
| Robert Atchinson | 3.4% | ||||
| Phillip Gross | 3.4% | ||||
|
General Catalyst Global Resilience Merger Corp.
13G
GCGR · G3793T104
|
7.7% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 7.7% | ||||
| Robert Atchinson | 7.7% | ||||
| Phillip Gross | 7.7% | ||||
|
ACP Holdings Acquisition Corp.
13G
ACGC · G0113G101
|
8.2% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 8.2% | ||||
| Robert Atchinson | 8.2% | ||||
| Phillip Gross | 8.2% | ||||
|
Snow Rothschild Acquisition Corp.
13G
ISNRU · G8251A125
|
8.0% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 8.0% | ||||
| Robert Atchinson | 8.0% | ||||
| Phillip Gross | 8.0% | ||||
|
Forte Biosciences, Inc.
13G/A
Amendment 1
FBRX · 34962G208
|
3.4% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 3.4% | ||||
| Robert Atchinson | 3.4% | ||||
| Phillip Gross | 3.4% | ||||
|
Traws Pharma, Inc.
13G/A
Amendment 1
TRAW · 68232V884
|
4.8% |
8/12/2026
Event 6/30/2026
|
|||
| Adage Capital Management, L.P. | 4.8% | ||||
| Robert Atchinson | 4.8% | ||||
| Phillip Gross | 4.8% | ||||
|
Nine Energy Service, Inc.
13G
NINE · 65441V200
|
9.7% |
7/9/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 9.7% | ||||
| Robert Atchinson | 9.7% | ||||
| Phillip Gross | 9.7% | ||||
|
X3 Acquisition Corp. Ltd.
13G
XCBE · G9831H101
|
8.0% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 8.0% | ||||
| Robert Atchinson | 8.0% | ||||
| Phillip Gross | 8.0% | ||||
|
Willow Lane Acquisition Corp. II
13G
WLII · G9675K103
|
6.7% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 6.7% | ||||
| Robert Atchinson | 6.7% | ||||
| Phillip Gross | 6.7% | ||||
|
TRG Latin America Acquisitions Corp.
13G
TRGS · G9037S109
|
8.6% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 8.6% | ||||
| Robert Atchinson | 8.6% | ||||
| Phillip Gross | 8.6% | ||||
|
SUMA Acquisition Corporation
13G
SUMA · G8557R103
|
7.6% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.6% | ||||
| Robert Atchinson | 7.6% | ||||
| Phillip Gross | 7.6% | ||||
|
Spring Valley Acquisition Corp. IV
13G
SVIV · G8377G105
|
7.8% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.8% | ||||
| Robert Atchinson | 7.8% | ||||
| Phillip Gross | 7.8% | ||||
|
Spartacus Acquisition Corp. II
13G
TMTSU · G8303R126
|
7.8% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.8% | ||||
| Robert Atchinson | 7.8% | ||||
| Phillip Gross | 7.8% | ||||
|
Space Asset Acquisition Corp.
13G
SAAQ · G8375S101
|
7.6% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.6% | ||||
| Robert Atchinson | 7.6% | ||||
| Phillip Gross | 7.6% | ||||
|
Soren Acquisition Corp.
13G
SORN · G8274J103
|
7.5% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.5% | ||||
| Robert Atchinson | 7.5% | ||||
| Phillip Gross | 7.5% | ||||
|
QDRO Acquisition Corp.
13G
QADRU · G7310E128
|
7.5% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.5% | ||||
| Robert Atchinson | 7.5% | ||||
| Phillip Gross | 7.5% | ||||
|
Presidio Production Company
13G
FTW · G3106N109
|
10.0% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 10.0% | ||||
| Robert Atchinson | 10.0% | ||||
| Phillip Gross | 10.0% | ||||
|
Paloma Acquisition Corp I
13G
PALO · G6881J102
|
8.0% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 8.0% | ||||
| Robert Atchinson | 8.0% | ||||
| Phillip Gross | 8.0% | ||||
|
Opus Genetics, Inc.
13G
IRD · 67577R102
|
8.5% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 8.5% | ||||
| Robert Atchinson | 8.5% | ||||
| Phillip Gross | 8.5% | ||||
|
OneIM Acquisition Corp.
13G
OIM · G6S74K106
|
7.8% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.8% | ||||
| Robert Atchinson | 7.8% | ||||
| Phillip Gross | 7.8% | ||||
|
Muzero Acquisition Corp
13G
MUZE · G8775A106
|
7.6% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.6% | ||||
| Robert Atchinson | 7.6% | ||||
| Phillip Gross | 7.6% | ||||
|
Mountain Lake Acquisition Corp. II
13G
MLAA · G6301L109
|
5.7% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 5.7% | ||||
| Robert Atchinson | 5.7% | ||||
| Phillip Gross | 5.7% | ||||
|
Monro, Inc.
13G
MNRO · 610236101
|
5.2% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 5.2% | ||||
| Robert Atchinson | 5.2% | ||||
| Phillip Gross | 5.2% | ||||
|
Metals Acquisition Corp. II
13G
MTAL · G60420109
|
7.8% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.8% | ||||
| Robert Atchinson | 7.8% | ||||
| Phillip Gross | 7.8% | ||||
|
M Evo Global Acquisition Corp II
13G
MEVO · G6071J102
|
8.1% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 8.1% | ||||
| Robert Atchinson | 8.1% | ||||
| Phillip Gross | 8.1% | ||||
|
Legato Merger Corp. IV
13G
LEGO · G7318R105
|
5.8% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 5.8% | ||||
| Robert Atchinson | 5.8% | ||||
| Phillip Gross | 5.8% | ||||
|
KRAKacquisition Corp
13G
KRAQ · G5315G106
|
7.2% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.2% | ||||
| Robert Atchinson | 7.2% | ||||
| Phillip Gross | 7.2% | ||||
|
Karyopharm Therapeutics Inc.
13G
KPTI · 48576U205
|
8.1% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 8.1% | ||||
| Robert Atchinson | 8.1% | ||||
| Phillip Gross | 8.1% | ||||
|
Iris Acquisition Corp II
13G
IRAB · G4940M109
|
7.8% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.8% | ||||
| Robert Atchinson | 7.8% | ||||
| Phillip Gross | 7.8% | ||||
|
Wave Life Sciences Ltd.
13G/A
Amendment 6
WVE · Y95308105
|
0.5% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 0.5% | ||||
| Robert Atchinson | 0.5% | ||||
| Phillip Gross | 0.5% | ||||
|
Infinite Eagle Acquisition Corp.
13G
IEAG · G4802J103
|
6.5% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 6.5% | ||||
| Robert Atchinson | 6.5% | ||||
| Phillip Gross | 6.5% | ||||
|
Inflection Point Acquisition Corp. VI
13G
IPFXU · G4790S123
|
5.9% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 5.9% | ||||
| Robert Atchinson | 5.9% | ||||
| Phillip Gross | 5.9% | ||||
|
Terns Pharmaceuticals, Inc.
13G/A
Amendment 1
TERN · 880881107
|
1.8% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 1.8% | ||||
| Robert Atchinson | 1.8% | ||||
| Phillip Gross | 1.8% | ||||
|
Tango Therapeutics, Inc.
13G/A
Amendment 1
TNGX · 87583X109
|
9.0% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 9.0% | ||||
| Robert Atchinson | 9.0% | ||||
| Phillip Gross | 9.0% | ||||
|
Hennessy Capital Investment Corp. VIII
13G
HCIC · G44055104
|
7.6% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.6% | ||||
| Robert Atchinson | 7.6% | ||||
| Phillip Gross | 7.6% | ||||
|
Seadrill Ltd
13G/A
Amendment 3
SDRL · G7997W102
|
3.9% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 3.9% | ||||
| Robert Atchinson | 3.9% | ||||
| Phillip Gross | 3.9% | ||||
|
Fortress Value Acquisition Corp. V
13G
FVAV · G3645T104
|
7.8% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.8% | ||||
| Robert Atchinson | 7.8% | ||||
| Phillip Gross | 7.8% | ||||
|
Relmada Therapeutics, Inc.
13G/A
Amendment 1
RLMD · 75955J402
|
4.5% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 4.5% | ||||
| Robert Atchinson | 4.5% | ||||
| Phillip Gross | 4.5% | ||||
|
Northpointe Bancshares, Inc.
13G/A
Amendment 1
NPB · 66661N886
|
7.5% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.5% | ||||
| Robert Atchinson | 7.5% | ||||
| Phillip Gross | 7.5% | ||||
|
Forte Biosciences, Inc.
13G
FBRX · 34962G208
|
6.8% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 6.8% | ||||
| Robert Atchinson | 6.8% | ||||
| Phillip Gross | 6.8% | ||||
|
FG Imperii Acquisition Corp.
13G
FGII · G3R41C102
|
7.8% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.8% | ||||
| Robert Atchinson | 7.8% | ||||
| Phillip Gross | 7.8% | ||||
|
Nabors Industries Ltd.
13G/A
Amendment 1
NBR · G6359F137
|
4.7% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 4.7% | ||||
| Robert Atchinson | 4.7% | ||||
| Phillip Gross | 4.7% | ||||
|
Columbus Circle Capital Corp II
13G
IPXG · G2296M103
|
7.6% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.6% | ||||
| Robert Atchinson | 7.6% | ||||
| Phillip Gross | 7.6% | ||||
|
Cambridge Acquisition Corp.
13G
CAQ · G1871M108
|
7.7% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.7% | ||||
| Robert Atchinson | 7.7% | ||||
| Phillip Gross | 7.7% | ||||
|
Monopar Therapeutics
13G/A
Amendment 1
MNPR · 61023L207
|
6.2% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 6.2% | ||||
| Robert Atchinson | 6.2% | ||||
| Phillip Gross | 6.2% | ||||
|
Blue Water Acquisition Corp. IV
13G
BWIVU · G1368A120
|
8.4% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 8.4% | ||||
| Robert Atchinson | 8.4% | ||||
| Phillip Gross | 8.4% | ||||
|
Milestone Pharmaceuticals Inc.
13G/A
Amendment 1
MIST · 59935V107
|
6.4% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 6.4% | ||||
| Robert Atchinson | 6.4% | ||||
| Phillip Gross | 6.4% | ||||
|
Metropolitan Bank Holding Corp.
13G/A
Amendment 1
MCB · 591774104
|
4.8% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 4.8% | ||||
| Robert Atchinson | 4.8% | ||||
| Phillip Gross | 4.8% | ||||
|
Bleichroeder Acquisition Corp. II
13G
BBCQ · G1170E104
|
7.8% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.8% | ||||
| Robert Atchinson | 7.8% | ||||
| Phillip Gross | 7.8% | ||||
|
MeiraGTx Holdings plc
13G/A
Amendment 6
MGTX · G59665102
|
4.9% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 4.9% | ||||
| Robert Atchinson | 4.9% | ||||
| Phillip Gross | 4.9% | ||||
|
Averin Capital Acquisition Corp.
13G
ACAA · G0679A100
|
8.9% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 8.9% | ||||
| Robert Atchinson | 8.9% | ||||
| Phillip Gross | 8.9% | ||||
|
Inovio Pharmaceuticals, Inc.
13G/A
Amendment 1
INO · 45773H409
|
5.8% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 5.8% | ||||
| Robert Atchinson | 5.8% | ||||
| Phillip Gross | 5.8% | ||||
|
Atara Biotherapeutics, Inc.
13G
ATRA · 046513206
|
8.6% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 8.6% | ||||
| Robert Atchinson | 8.6% | ||||
| Phillip Gross | 8.6% | ||||
|
Heron Therapeutics, Inc.
13G/A
Amendment 1
HRTX · 427746102
|
0% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 0% | ||||
| Robert Atchinson | 0% | ||||
| Phillip Gross | 0% | ||||
|
Armada Acquisition Corp. III
13G
AACI · G0R38M101
|
7.9% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.9% | ||||
| Robert Atchinson | 7.9% | ||||
| Phillip Gross | 7.9% | ||||
|
EyePoint, Inc.
13G/A
Amendment 7
EYPT · 30233G209
|
4.0% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 4.0% | ||||
| Robert Atchinson | 4.0% | ||||
| Phillip Gross | 4.0% | ||||
|
Archimedes Tech SPAC Partners III Co.
13G
ARCI · G0453R105
|
5.1% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 5.1% | ||||
| Robert Atchinson | 5.1% | ||||
| Phillip Gross | 5.1% | ||||
|
DBV Technologies S.A.
13G/A
Amendment 1
DBVT · 23306J309
|
7.3% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.3% | ||||
| Robert Atchinson | 7.3% | ||||
| Phillip Gross | 7.3% | ||||
|
Aldabra 4 Liquidity Opportunity Vehicle, Inc.
13G
ALOV · G01900102
|
5.8% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 5.8% | ||||
| Robert Atchinson | 5.8% | ||||
| Phillip Gross | 5.8% | ||||
|
Centessa Pharmaceuticals plc
13G/A
Amendment 3
CNTA · 152309100
|
5.8% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 5.8% | ||||
| Robert Atchinson | 5.8% | ||||
| Phillip Gross | 5.8% | ||||
|
Adagio Medical Holdings, Inc.
13G/A
Amendment 2
ADGM · 00534B100
|
5.7% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 5.7% | ||||
| Robert Atchinson | 5.7% | ||||
| Phillip Gross | 5.7% | ||||
|
Abony Acquisition Corp. I
13G
AACO · G00582109
|
7.6% |
5/13/2026
Event 3/31/2026
|
|||
| Adage Capital Management, L.P. | 7.6% | ||||
| Robert Atchinson | 7.6% | ||||
| Phillip Gross | 7.6% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.